Vimarsana
Biggest News Aggregation in the World

Allen Davidoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allen Davidoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allen Davidoff Today - Breaking & Trending Today

XORTX Reprices Warrants Issued in Connection with Previous - Vimarsana News

XORTX Reprices Warrants Issued in Connection with Previous

CALGARY, Alberta, April 30, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

Money Talk Radio with Ellis Martin: XORTX Therapeutics Inc. (NASDAQ:XRTX) (CVE:XRTX) Dr. Allen Davidoff-Look for More M&As in the Kidney Disease Remediation Space in the Future - Vimarsana News

Money Talk Radio with Ellis Martin: XORTX Therapeutics Inc. (NASDAQ:XRTX) (CVE:XRTX) Dr. Allen Davidoff-Look for More M&As in the Kidney Disease Remediation Space in the Future

In this segment of Money Talk Radio with Ellis Martin, we speak with Dr. Allen Davidoff, CEO of XORTX Therapeutics (NASDAQ:XRTX) (CVE:XRTX), a pioneer in developing new therapies for progressive kidney disease and diabetes.

XORTX Therapeutics : CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K -April 04, 2024 at 06:04 am EDT - Vimarsana News

XORTX Therapeutics : CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K -April 04, 2024 at 06:04 am EDT

CONSOLIDATED FINANCIAL STATEMENTS AS AT AND FOR THE YEARS ENDED DECEMBER 31, 2023, 2022 and 2021 REPORT OF INDEPENDENT REGISTERED PUBLIC...

XORTX Announces New Clinical Advisory Board Member - Vimarsana News

XORTX Announces New Clinical Advisory Board Member

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (

XORTX Announces New Clinical Advisory Board Member - XORTX Therapeutics (NASDAQ:XRTX) - Vimarsana News

XORTX Announces New Clinical Advisory Board Member - XORTX Therapeutics (NASDAQ:XRTX)

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANUA WKN: A3UNZ)), a biopharmaceutical company focused on developing